Literature DB >> 21561556

Recanalization rates after endovascular coil embolization in a cohort of matched ruptured and unruptured cerebral aneurysms.

I Y L Tan1, R F Agid, R A Willinsky.   

Abstract

The aim of this study was to retrospectively assess the recanalization rate, factors associated with and time taken for recanalization to occur in a matched ruptured and unruptured aneurysm population that were treated with endovascular coiling.Ruptured and unruptured aneurysms treated between 2002 and 2007 were matched for aneurysm location, diameter and neck size. Recanalization rate, time to recanalize, re-treatment rate and clinical outcome were analysed. Ninety-eight matched ruptured and unruptured aneurysms (49 aneurysms in each group) were studied. 46.8% of aneurysms in the ruptured group achieved complete obliteration on the initial post treatment angiogram versus 34.7% in the unruptured group. The ruptured group had a higher rate of recanalization (40.4% versus 20.4%). 25.5% of aneurysms had significant recanalization in the ruptured group versus 6.1% in the unruptured group (p=0.009). The retreatment rate was higher in the ruptured group (21.3% versus 6%). Ruptured aneurysms took a shorter time to recanalize with a mean time of 5.3±3.8 months versus 12.4±7.7months (p=0.003). Multivariate logistic regression analysis found neck size (p=0.0098), wide neck morphology (p=0.0174), aneurysm diameter (p< 0.0001) and ruptured aneurysms (p=0.0372) were significant predictors of recanalization. The majority of patients in both groups had a good outcome with GOS=5 (85.7% and 83.7%) but two deaths occurred in the ruptured group.Ruptured and unruptured aneurysms showed significant differences in rate, degree and timing of recanalization, thus requiring different protocols for imaging follow-up post endovascular treatment. Earlier and more frequent imaging follow-up is recommended for ruptured aneurysms.

Entities:  

Mesh:

Year:  2011        PMID: 21561556      PMCID: PMC3278032          DOI: 10.1177/159101991101700106

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  29 in total

1.  Is the aspect ratio a reliable index for predicting the rupture of a saccular aneurysm?

Authors:  H Ujiie; Y Tamano; K Sasaki; T Hori
Journal:  Neurosurgery       Date:  2001-03       Impact factor: 4.654

2.  Influence of perianeurysmal environment on the deformation and bleb formation of the unruptured cerebral aneurysm: assessment with fusion imaging of 3D MR cisternography and 3D MR angiography.

Authors:  Toru Satoh; Megumi Omi; Chika Ohsako; Atsushi Katsumata; Yusuke Yoshimoto; Shoji Tsuchimoto; Keisuke Onoda; Koji Tokunaga; Kenji Sugiu; Isao Date
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

3.  Comparison of 2D digital subtraction angiography and 3D rotational angiography in the evaluation of dome-to-neck ratio.

Authors:  W Brinjikji; H Cloft; G Lanzino; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2009-01-08       Impact factor: 3.825

4.  Endovascular treatment of unruptured aneurysms.

Authors:  D Roy; G Milot; J Raymond
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

5.  Recanalization after endovascular treatment of intracerebral aneurysms.

Authors:  Iris Q Grunwald; Panagiotis Papanagiotou; Tobias Struffert; Maria Politi; Christoph Krick; Gökmen Gül; Wolfgang Reith
Journal:  Neuroradiology       Date:  2006-11-09       Impact factor: 2.804

6.  Clinical and angiographic follow-up of ruptured intracranial aneurysms treated with endovascular embolization.

Authors:  R A Willinsky; J Peltz; L da Costa; R Agid; R I Farb; K G terBrugge
Journal:  AJNR Am J Neuroradiol       Date:  2009-03-19       Impact factor: 3.825

7.  Characterization of aneurysm remnants after endovascular treatment: contrast-enhanced MR angiography versus catheter digital subtraction angiography.

Authors:  R Agid; R A Willinsky; S-K Lee; K G Terbrugge; R I Farb
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-22       Impact factor: 3.825

8.  In vitro measurement of fluid-induced wall shear stress in unruptured cerebral aneurysms harboring blebs.

Authors:  Satoshi Tateshima; Yuichi Murayama; J Pablo Villablanca; Taku Morino; Kiyoe Nomura; Kazuo Tanishita; Fernando Viñuela
Journal:  Stroke       Date:  2003-01       Impact factor: 7.914

9.  Comparison of ruptured vs unruptured aneurysms in recanalization after coil embolization.

Authors:  Thanh N Nguyen; Brian L Hoh; Sepideh Amin-Hanjani; Johnny C Pryor; Christopher S Ogilvy
Journal:  Surg Neurol       Date:  2007-02-15

10.  International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion.

Authors:  Andrew J Molyneux; Richard S C Kerr; Ly-Mee Yu; Mike Clarke; Mary Sneade; Julia A Yarnold; Peter Sandercock
Journal:  Lancet       Date:  2005 Sep 3-9       Impact factor: 79.321

View more
  19 in total

1.  Endovascular Coil Embolization of Distal Anterior Cerebral Artery Aneurysms: Angiographic and Clinical Follow-up Results.

Authors:  Hyun Seok Park; Soon Chan Kwon; Min-Ho Kim; Eun Suk Park; Hong Bo Sim; In Uk Lyo
Journal:  Neurointervention       Date:  2013-08-29

2.  Tungsten coil disappearance and SAH recurrence 12 years after endovascular embolisation.

Authors:  Ding Ya-Suo; Lin Yu-Chang
Journal:  Clin Neuroradiol       Date:  2013-05-08       Impact factor: 3.649

3.  The Orbit Galaxy XTRASOFT Coils: A Multicenter Study of Coil Safety and Efficacy in Both Ruptured and Unruptured Cerebral Aneurysms.

Authors:  Ahmad Khaldi; Kyle M Fargen; Ben Waldau; Adnan H Siddiqui; Brian L Hoh; William Mack; Jeffrey Carpenter; Erol Veznedaroglu; J Mocco
Journal:  J Vasc Interv Neurol       Date:  2012-06

Review 4.  Recurrence of endovascularly and microsurgically treated intracranial aneurysms-review of the putative role of aneurysm wall biology.

Authors:  Serge Marbacher; Mika Niemelä; Juha Hernesniemi; Juhana Frösén
Journal:  Neurosurg Rev       Date:  2017-08-17       Impact factor: 3.042

5.  Predictors of success following endovascular retreatment of intracranial aneurysms.

Authors:  Justin R Mascitelli; Eric K Oermann; J Mocco; Johanna T Fifi; Srinivasan Paramasivam; Christopher J Stapleton; Aman B Patel
Journal:  Interv Neuroradiol       Date:  2015-06-19       Impact factor: 1.610

6.  Treatment of Ruptured and Nonruptured Aneurysms Using a Semisolid Iodinated Embolic Agent.

Authors:  Zefu Zhang; Hassan Albadawi; Richard J Fowl; Izzet Altun; Marcela A Salomao; Jama Jahanyar; Brian W Chong; Joseph L Mayer; Rahmi Oklu
Journal:  Adv Mater       Date:  2022-01-21       Impact factor: 30.849

Review 7.  Predictors of aneurysm occlusion following treatment with the WEB device: systematic review and case series.

Authors:  Fadi Al Saiegh; Lohit Velagapudi; Omaditya Khanna; Ahmad Sweid; Nikolaos Mouchtouris; Michael P Baldassari; Thana Theofanis; Rizwan Tahir; Victoria Schunemann; Carrie Andrews; Lucas Philipp; Nohra Chalouhi; Stavropoula I Tjoumakaris; David Hasan; M Reid Gooch; Nabeel A Herial; Robert H Rosenwasser; Pascal Jabbour
Journal:  Neurosurg Rev       Date:  2021-09-04       Impact factor: 3.042

8.  Analysis of Multiple Intracranial Aneurysms with Different Outcomes in the Same Patient After Endovascular Treatment.

Authors:  Linkai Jing; Jian Liu; Ying Zhang; Nikhil Paliwal; Hui Meng; Shengzhang Wang; Xinjian Yang
Journal:  World Neurosurg       Date:  2016-04-27       Impact factor: 2.104

Review 9.  Factors affecting formation and rupture of intracranial saccular aneurysms.

Authors:  S Bacigaluppi; M Piccinelli; L Antiga; A Veneziani; T Passerini; P Rampini; M Zavanone; P Severi; G Tredici; G Zona; T Krings; E Boccardi; S Penco; M Fontanella
Journal:  Neurosurg Rev       Date:  2013-12-04       Impact factor: 3.042

10.  CE-MRA for follow-up of aneurysms post stent-assisted coiling.

Authors:  R Agid; M Schaaf; Ri Farb
Journal:  Interv Neuroradiol       Date:  2012-09-10       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.